| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |